Cybersickness imAgiNg Olfactory Evocation (CANOE)

November 4, 2022 updated by: Cécile RUMEAU, Central Hospital, Nancy, France

The aim of this study is to, using fMRI, compare brain activations during olfactory imagery induced by different visual supports (words, pictures, colors and colored arrangements) in healthy subjects.

This will allow us to choose the best olfactory imagery facilitator and to assess its effect on cybersickness.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nancy, France
        • CHRU Nancy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • to be of French nationality who has always lived in metropolitan France;
  • to be right-handed person;
  • to be enrolled in a social security plan;
  • to be able to understand the instructions given;
  • to have underwent a pre-inclusion medical examination;
  • to give a written consent;
  • Person with a strong capacity for olfactory imagination: having obtained a score strictly below 2.5 on the fVOIQ olfactory imagination questionnaire.

Exclusion Criteria:

  • to have an inability to read French;
  • to be recognized as a synesthete;
  • to have a professional activity requires intense olfactory activity;
  • to have a partial or total loss of smell (hyposmia, anosmia);
  • to have qualitative smell disorders (carcosomia, hyperosmia, phantosmia, parosmia);
  • to have smell disorders of neurological, post-traumatic or neurodegenerative origin;
  • to have uncorrected or poorly corrected visual disturbances;
  • to have vestibular disorder diagnosed;
  • any contraindication to MR examination (active medical device, ferromagnetic foreign body, pregnancy, morbid obesity, claustrophobia, … );
  • subject under a measure of legal protection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
The volunteer will have to imagine the smells evoked by different visual aids. This task will be carried out during 2 acquisition runs of about 10 minutes each. The volunteer should note (on a scale from 1 to 4) the pleasantness of the smell evoked.
Other Names:
  • fMRI
The volunteer will be immersed in a virtual maritime environment with nauseating characteristics. In the center of the maritime scene, it will be visible the black outlines of a frame. Every minute, the volunteer will be asked to verbalize the level of his general condition via the Fast Motion Sickness Scale (1 to 20).
Other Names:
  • VR control
The volunteer will be immersed in a virtual maritime environment with nauseating characteristics. The visual support inserted in the center of the virtual scene will be the one defined as being the most facilitator of the olfactory imagination during the fMRI examination. The volunteer will be asked to concentrate on the smell evoked by this support. Every minute, the volunteer will be asked to verbalize the level of his general condition via the Fast Motion Sickness Scale (1 to 20).
Other Names:
  • VR experimental

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of cerebral activations between the different supports mediating the olfactory imagination during the execution of the fMRI tasks.
Time Frame: Baseline (J0)
The cerebral activations between the different supports mediating the olfactory imagination will be compared in terms of localization and intensity of the variations of the BOLD signal during the execution of the fMRI tasks.
Baseline (J0)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determination of the visual support allowing the strongest olfactory imagination during the fMRI by subjective evaluations using two 4-level Likert scales.
Time Frame: Baseline (J0)
Subjective evaluations will be carried out using two 4-level Likert scales.
Baseline (J0)
Determination of the visual support allowing the strongest olfactory imagination during the fMRI test by the cerebral activations in areas recognized for their implications in the olfactory imagination.
Time Frame: Baseline (J0)
The cerebral activations will be measured by the intensity of the variations of the BOLD signal during the execution of the fMRI tasks.
Baseline (J0)
Description of the evolution of the cardiac activity during olfactory imagination tasks in fMRI.
Time Frame: Baseline (J0)
The cardiac activity will be evaluated by the R-wave interval. The cardiac activity will be recorded via the ECG during olfactory imagination tasks in fMRI.
Baseline (J0)
Description of the evolution of the respiratory activity during olfactory imagination tasks in fMRI.
Time Frame: Baseline (J0)
The respiratory activity will be evaluated by the respiratory rate. The respiratory activity will be recorded via the respiratory belt during olfactory imagination tasks in fMRI.
Baseline (J0)
Evaluation of the state of discomfort in virtual reality by measuring the cardiac activity.
Time Frame: Baseline (J0) and 6 months maximum after J0 (V1)
Cardiac activity will be evaluated by the R-wave interval. Cardiac activity during immersion will be recorded by the cardio-respiratory belt.
Baseline (J0) and 6 months maximum after J0 (V1)
Evaluation of the state of discomfort in virtual reality by the "Simulator Sickness Questionnaire" (SSQ) before and after immersion.
Time Frame: Baseline (J0) and 6 months maximum after J0 (V1)
The participant will answer to the "Simulator Sickness Questionnaire" (SSQ) before and after immersion (minimum=0 and maximum=235,62). A higher score means a more severe discomfort.
Baseline (J0) and 6 months maximum after J0 (V1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 13, 2022

Primary Completion (Actual)

July 12, 2022

Study Completion (Actual)

October 26, 2022

Study Registration Dates

First Submitted

March 4, 2022

First Submitted That Met QC Criteria

March 24, 2022

First Posted (Actual)

April 4, 2022

Study Record Updates

Last Update Posted (Actual)

November 7, 2022

Last Update Submitted That Met QC Criteria

November 4, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2021-A02854-37

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Functional MRI

3
Subscribe